CDP 146
Latest Information Update: 16 Jul 2007
At a glance
- Originator UCB
- Class
- Mechanism of Action P38 mitogen-activated protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 08 Dec 2003 Preclinical trials in Inflammation in United Kingdom (PO)